Bayesian Capital Management LP acquired a new stake in shares of Waters Corporation (NYSE:WAT) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,334 shares of the medical instruments supplier’s stock, valued at approximately $613,000.

Several other large investors also recently made changes to their positions in WAT. UBS Asset Management Americas Inc. grew its stake in shares of Waters Corporation by 8.5% during the 1st quarter. UBS Asset Management Americas Inc. now owns 255,342 shares of the medical instruments supplier’s stock valued at $39,913,000 after acquiring an additional 20,028 shares during the period. Ameriprise Financial Inc. grew its stake in shares of Waters Corporation by 2.3% during the 1st quarter. Ameriprise Financial Inc. now owns 107,159 shares of the medical instruments supplier’s stock valued at $16,754,000 after acquiring an additional 2,391 shares during the period. Raymond James Financial Services Advisors Inc. grew its stake in shares of Waters Corporation by 3.2% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 6,472 shares of the medical instruments supplier’s stock valued at $1,012,000 after acquiring an additional 199 shares during the period. Pacer Advisors Inc. grew its stake in shares of Waters Corporation by 3.2% during the 1st quarter. Pacer Advisors Inc. now owns 1,651 shares of the medical instruments supplier’s stock valued at $258,000 after acquiring an additional 51 shares during the period. Finally, Victory Capital Management Inc. grew its stake in shares of Waters Corporation by 6.0% during the 1st quarter. Victory Capital Management Inc. now owns 9,170 shares of the medical instruments supplier’s stock valued at $1,433,000 after acquiring an additional 515 shares during the period. Institutional investors own 91.00% of the company’s stock.

In other news, SVP Rohit Khanna sold 18,400 shares of Waters Corporation stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the sale, the senior vice president now directly owns 22,477 shares of the company’s stock, valued at $4,175,777.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Christopher A. Kuebler sold 3,500 shares of Waters Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the completion of the sale, the director now directly owns 17,849 shares in the company, valued at $3,206,929.83. The disclosure for this sale can be found here. Insiders own 5.07% of the company’s stock.

Waters Corporation (NYSE:WAT) traded up 0.41% during mid-day trading on Friday, reaching $179.52. The company had a trading volume of 334,977 shares. Waters Corporation has a 52 week low of $133.35 and a 52 week high of $190.39. The stock has a market capitalization of $14.33 billion, a price-to-earnings ratio of 27.06 and a beta of 0.83. The stock has a 50 day moving average of $181.80 and a 200 day moving average of $174.21.

Waters Corporation (NYSE:WAT) last issued its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.05. The firm had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The business’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.58 earnings per share. Analysts anticipate that Waters Corporation will post $7.39 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://www.watchlistnews.com/bayesian-capital-management-lp-takes-613000-position-in-waters-corporation-wat/1598576.html.

A number of research analysts recently issued reports on WAT shares. Zacks Investment Research upgraded Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price objective for the company in a research note on Thursday, July 13th. BidaskClub downgraded Waters Corporation from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 28th. Jefferies Group LLC restated a “hold” rating and issued a $175.00 price target on shares of Waters Corporation in a research note on Thursday, July 27th. Deutsche Bank AG downgraded Waters Corporation from a “buy” rating to a “hold” rating and upped their price target for the stock from $183.00 to $194.00 in a research note on Monday, July 10th. Finally, Cowen and Company restated a “hold” rating and issued a $190.00 price target on shares of Waters Corporation in a research note on Friday, July 14th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Waters Corporation has a consensus rating of “Hold” and a consensus target price of $185.50.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.